These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3293414)

  • 1. The probucol experience: a review of the past and a look at the future.
    Schwartz CJ
    Am J Cardiol; 1988 Jul; 62(3):1B-5B. PubMed ID: 3293414
    [No Abstract]   [Full Text] [Related]  

  • 2. Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 Jun; 15(6):409-28. PubMed ID: 350557
    [No Abstract]   [Full Text] [Related]  

  • 3. Probucol in long-term treatment of hypercholesterolemia.
    Strandberg TE; Vanhanen H; Miettinen TA
    Gen Pharmacol; 1988; 19(3):317-20. PubMed ID: 3046993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    Walldius G; Carlson LA; Erikson U; Olsson AG; Johansson J; Mölgaard J; Nilsson S; Stenport G; Kaijser L; Lassvik C
    Am J Cardiol; 1988 Jul; 62(3):37B-43B. PubMed ID: 3293415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of anti-atherogenic effect of probucol and the prospects of its clinical use].
    Lankin VZ; Lupanov VP; Liakishev AA; Revenko VM
    Kardiologiia; 1991 Jun; 31(6):87-90. PubMed ID: 1921141
    [No Abstract]   [Full Text] [Related]  

  • 6. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
    Glueck CJ
    Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with probucol in the treatment of hypercholesterolemia.
    Davignon J; Lussier-Cacan S; Dubreuil-Quidoz S; LeLorier J
    Artery; 1982; 10(1):48-55. PubMed ID: 7092576
    [No Abstract]   [Full Text] [Related]  

  • 8. Probucol in hypercholesterolemia.
    Howard PA
    DICP; 1989 Nov; 23(11):880-2. PubMed ID: 2596130
    [No Abstract]   [Full Text] [Related]  

  • 9. Probucol, a new cholesterol lowering drug.
    Nash DT
    J Med; 1975; 6(5-6):305-15. PubMed ID: 768396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A symposium: Second International Conference on Hypercholesterolemia--examining new data on probucol after a decade of use.
    Am J Cardiol; 1988 Jul; 62(3):1B-81B. PubMed ID: 3394647
    [No Abstract]   [Full Text] [Related]  

  • 11. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Probucol in the treatment of hypercholesterolemia].
    da Cunha GP; da Cunha CL
    Arq Bras Cardiol; 1981 Jul; 37(1):63-6. PubMed ID: 7348171
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of probucol in treating primary hypercholesterolemia.
    Enjalbert M; Lussier-Cacan S; DuBreuil-Quidoz S; LeLorier J; Davignon J
    Can Med Assoc J; 1980 Oct; 123(8):754-7. PubMed ID: 7448680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST).
    Walldius G; Regnström J; Nilsson J; Johansson J; Schäfer-Elinder L; Moelgaard J; Hådell K; Olsson AG; Carlson LA
    Am J Cardiol; 1993 Feb; 71(6):15B-19B. PubMed ID: 8434556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A symposium: New developments in the treatment of hypercholesterolemia--probucol. December 7, 1985, New York, New York.
    Am J Cardiol; 1986 Jun; 57(16):1H-54H. PubMed ID: 3728305
    [No Abstract]   [Full Text] [Related]  

  • 16. A symposium: new developments in the treatment of hypercholesterolemia--probucol. Introduction.
    Eder HA
    Am J Cardiol; 1986 Jun; 57(16):1H-2H. PubMed ID: 3728304
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with probucol with special emphasis on mode of action and long-term treatment.
    Miettinen TA; Huttunen JK; Kuusi T; Kumlin T; Mattila S; Naukkarinen V; Strandberg T
    Artery; 1982; 10(1):35-43. PubMed ID: 7092574
    [No Abstract]   [Full Text] [Related]  

  • 18. Probucol: a new cholesterol-lowering drug effective in patients with type II hyperlipoproteinemia.
    Salel AF; Zelis R; Sodhi HS; Price J; Mason DT
    Clin Pharmacol Ther; 1976 Dec; 20(6):690-4. PubMed ID: 186224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of probucol in the control of hypercholesterolemia].
    Quintão EC; Maranhão RC
    Arq Bras Cardiol; 1980 Apr; 34(4):331-3. PubMed ID: 7002123
    [No Abstract]   [Full Text] [Related]  

  • 20. [Probucol in patients with diabetes mellitus type II with hypercholesterolemia].
    Fonteles MC; Costa e Forti A; de Freitas MT
    Arq Bras Cardiol; 1987 Feb; 48(2):129-33. PubMed ID: 3314806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.